Colon Cancer Surveillance Follow-Up Cost: Colonoscopy, CT, and CEA Testing
In 2010, colon cancer surveillance meant a colonoscopy every year and a CT scan twice a year. Today, evidence-based guidelines have rationalized that schedule significantly — but the costs remain real and ongoing. If you’ve finished colon cancer treatment, here’s what the next 5 years of follow-up looks like financially, and how to make sure insurance covers what it should.
The National Cancer Institute estimates there are now over 1.1 million colon cancer survivors in the United States. The ASCO and NCCN surveillance guidelines they follow were last updated in 2023–2024, and they explicitly weigh the cost burden of follow-up — fewer tests, not more, unless symptoms or rising tumor markers warrant them.
Standard Surveillance Schedule (ASCO/NCCN Guidelines)
After curative-intent surgery for Stage I–III colon cancer:
| Test | Frequency | Purpose |
|---|---|---|
| CEA blood test | Every 3–6 months, years 1–3; every 6 months, years 4–5 | Detect recurrence early |
| CT chest/abdomen/pelvis | Every 6–12 months, years 1–3; annually, years 4–5 | Look for distant metastases |
| Colonoscopy | Year 1 post-surgery, then every 3–5 years if normal | Check for new polyps, anastomotic recurrence |
| Oncologist/surgeon visits | Every 3–6 months, years 1–2; then annually | Physical exam, symptom review, labs |
Stage IV patients with no evidence of disease after resection of metastases follow a more intensive schedule. Patients with Lynch syndrome or hereditary conditions have additional surveillance requirements (see Lynch syndrome screening costs).
Individual Test Costs
| Test/Visit | Cost Without Insurance | With Insurance (OOP Est.) |
|---|---|---|
| CEA blood test | $50–$200 | $10–$50 (after deductible) |
| CT chest/abdomen/pelvis (with contrast) | $2,000–$5,000 | $300–$1,500 |
| Colonoscopy (surveillance) | $1,800–$4,500 | $500–$2,500 |
| PET scan (if suspicion of recurrence) | $4,000–$8,000 | $800–$3,000 |
| MRI liver (if liver lesion suspected) | $2,000–$5,000 | $400–$2,000 |
| Oncologist follow-up visit | $250–$500 | $50–$200 |
| Surgical follow-up visit | $200–$450 | $40–$180 |
The CT scan is typically the biggest cost driver in the surveillance schedule. With the standard protocol of twice-yearly CTs for the first three years, that’s 6 CTs in years 1–3 alone — plus the year-one colonoscopy, CEA draws every 3 months, and quarterly visits.
Annual Cost Estimates by Year Post-Treatment
| Year Post-Surgery | Tests Included | Estimated Total (No Insurance) | With Insurance (OOP) |
|---|---|---|---|
| Year 1 | 2 CTs, colonoscopy, 4 CEAs, 4 visits | $10,000–$18,000 | $2,000–$6,000 |
| Year 2 | 2 CTs, 4 CEAs, 4 visits | $6,000–$12,000 | $1,200–$4,000 |
| Year 3 | 2 CTs, 4 CEAs, 4 visits | $6,000–$12,000 | $1,200–$4,000 |
| Year 4 | 1 CT, 2 CEAs, 2 visits | $3,500–$7,000 | $700–$2,500 |
| Year 5 | 1 CT, colonoscopy, 2 CEAs, 2 visits | $5,000–$10,000 | $1,000–$3,500 |
| 5-Year Total | $30,500–$59,000 | $6,100–$20,000 |
These estimates reflect uncomplicated surveillance — no findings requiring additional workup. If a scan shows a suspicious lesion, costs can spike dramatically: a PET scan ($4,000–$8,000), a liver biopsy ($3,000–$8,000), or discovery of resectable metastatic disease triggers an entirely new treatment cost cycle.
Is Surveillance Colonoscopy Covered as Preventive?
This matters. Colonoscopy cost coverage depends entirely on how it’s coded. A surveillance colonoscopy for a colon cancer survivor is NOT the same as a routine screening colonoscopy under the ACA’s preventive services provision.
Routine ACA screening colonoscopy: Free, no cost-sharing, for average-risk adults. This is a wellness benefit.
Surveillance colonoscopy for cancer survivors: Billed as a diagnostic procedure. Subject to your deductible and coinsurance — typically $500–$2,500 depending on your plan.
This catches many cancer survivors off guard. They’ve heard “colonoscopies are free” and don’t realize that designation doesn’t apply to their situation. Ask your GI office how they’ll code your surveillance colonoscopy before the procedure.
How Insurers Classify Post-Cancer Surveillance
Under most commercial plans and Medicare, post-cancer surveillance tests are covered as medically necessary diagnostic services — not preventive. This means:
- Subject to deductible (you pay first)
- Subject to coinsurance (you pay 20–30% after deductible)
- Count toward your out-of-pocket maximum
Medicare specifically: CT scans are covered under Part B at 80% after the deductible. CEA tests are covered under Part B. Surveillance colonoscopy is covered under Part B as a diagnostic colonoscopy (not free like the preventive screening benefit).
Medicare Coverage for Colon Cancer Surveillance
Part B covers:
- Diagnostic colonoscopy at 80% after deductible (deductible: $257 in 2026)
- CT scans at 80% after deductible
- CEA blood tests at 80% after deductible
- Oncologist and surgeon follow-up visits at 80% after deductible
What Medicare doesn’t cover well:
- The 20% coinsurance on imaging adds up significantly. A $3,000 CT scan = $600 out of pocket. Two per year = $1,200 in CT coinsurance alone, plus the deductible.
- Medigap (supplemental insurance) covers the 20% coinsurance. Survivors on Medicare should strongly consider Medigap Plan G or a Medicare Advantage plan with low imaging cost-sharing.
Commercial Insurance and Prior Authorization
Most commercial plans don’t require prior authorization for CEA blood tests. But CT scans and colonoscopies often do, particularly as surveillance continues beyond year 3.
For CT scans, authorization may be handled through a Radiology Benefits Manager (RBM) like National Imaging Associates or eviCore. These third parties review whether the scan is clinically appropriate — and may deny it if your oncologist hasn’t documented the clinical indication carefully.
Practical tip: Make sure your oncologist’s PA requests include:
- Diagnosis code (Z85.038 — personal history of malignant neoplasm of colon)
- Clinical rationale (post-resection surveillance per ASCO guidelines)
- Reference to specific guideline (ASCO 2023 Colorectal Cancer Surveillance Guideline)
A denial isn’t the end. You can appeal with the guideline citation and your oncologist’s letter. Most are overturned.
Managing Surveillance Costs Strategically
Stack tests in the same appointment. CEA draw, imaging read, and follow-up visit in one encounter may allow single facility fee/E&M billing rather than multiple separate charges.
Use an in-network imaging center, not the hospital. Hospital-based CT imaging often costs 50–80% more than a freestanding radiology center for the same scan. Specifically request an in-network outpatient radiology center when your oncologist orders imaging.
Time colonoscopies to your deductible year. If you’ve already hit your annual deductible (common in years with heavy treatment costs), having your surveillance colonoscopy before December 31 means it’s covered at your coinsurance rate, not counted toward next year’s new deductible.
Ask about telehealth follow-up. Stable, no-evidence-of-disease visits may qualify for telehealth, saving transportation costs and often having lower cost-sharing for routine follow-up.
Understand your cancer center’s financial assistance resources. Many NCI-designated cancer centers have oncology social workers and financial counselors who specialize in cancer survivor financial navigation. This service is typically free.
For patients whose cancer required polyp removal as part of the original diagnosis workup, understanding colon polyp removal costs and the follow-up colonoscopy cadence provides additional context on long-term surveillance expenses.
Genetic Testing: When It Affects Surveillance Frequency
If you have Lynch syndrome or another hereditary colorectal cancer syndrome, your surveillance schedule is more intensive — and costlier. Lynch syndrome screening with annual or biennial colonoscopy rather than every 3–5 years doubles or triples colonoscopy-related surveillance costs. See the detailed Lynch syndrome screening cost breakdown for the full picture.
Bottom line: Five years of standard surveillance for non-hereditary colon cancer will cost $6,000–$20,000 out of pocket for most insured patients. Planning for these ongoing costs — particularly the year-1 intensive phase — prevents unpleasant financial surprises after a treatment journey you’ve already endured.